Sean McKinley of Origin CBD explores the emerging dangers of synthetic and semi-synthetic cannabinoids in Europe, both for businesses and consumers.
Medical cannabis patients are often framed as consumers chasing the next strain, but that overlooks how many navigate treatment, writes Dave Barton.
Early research suggests CBG-A could support cardiovascular health and reduce oxidative stress.
Dr Simon Erridge reflects on some of the key findings published on medical cannabis this year.
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging […]
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through media headlines or marketing […]
Cannabis Europa panellist and Grow Group’s Managing Director, Pierre van Weperen, on the current state of play, and the future of cannabis-based medicine in the UK.
James Smith, co-founder of 4C Labs, shares his recent experience using cannabis-based medicines after a hip replacement.
Words by Dr Sue Clenton, Medical Director, Releaf If we are serious about the future of medical cannabis in the UK, we must be equally serious about its clinical […]
Dr Alexander Van Heerden: “Doctors Should See Cannabis as a First-Line Treatment Option”
Sponsored The international Cannabis scene dazzles aficionados with its variety of UK cannabis strains. Connoisseurs remain on a quest, aiming to discover cannabis strains that offer a transcendent experience. These […]
Adam Kavalier PhD, scientific director of Anthera Pharmaceuticals, explores what we know about medical cannabis in the treatment of PTSD.
Cristelle Santos, consultant toxicologist at Broughton Group, shares her experiences as a toxicologist in the CBD sector.
Michael Sassano, CEO and founder of SOMAÍ Pharmaceuticals, explores the latest developments in Ukraine.
Almost six years since the law change, children still struggle to access a consistent supply of medicine in the UK, writes Matt Hughes, Medcan Family Foundation.
Libby Clarke, managing consultant for Toxicology at Broughton, explores how CBD companies can optimise their testing strategies.
An expert explains everything you need to know about the entourage effect.
Michael Sassano CEO and founder of SOMAÍ Pharmaceuticals, explains how to find the right dose.
James Leavesley and Brady Green, head grower at Dalgety, discuss what insights the UK can glean from more advanced markets.
Dave Barton, co-founder and creative director at cannabis content agency, thermidor<, explores the challenges brands face in marketing medical cannabis and wonders whether any of them are actually doing it […]
Joe* shares how medical cannabis has been ‘life-changing’ for managing symptoms of vestibular migraine.
Experts explore how cannabis could play an important role in offering new treatment options.
A UK cannabis prescriber shares what he has learned on his journey so far.
Cannabis scientist Lex Pelger brings you the latest in cannabinoid research.
